• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

灭活新冠病毒疫苗对 B.1.617.2(德尔塔)变异株感染患者肺损伤的影响。

Impact of inactivated COVID-19 vaccines on lung injury in B.1.617.2 (Delta) variant-infected patients.

机构信息

School of Public Health, Nanjing Medical University, 101 Longmian Ave, Nanjing, 211166, China.

The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, Jiangsu, China.

出版信息

Ann Clin Microbiol Antimicrob. 2023 Mar 21;22(1):22. doi: 10.1186/s12941-023-00569-z.

DOI:10.1186/s12941-023-00569-z
PMID:36944961
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10029781/
Abstract

BACKGROUND

Chest computerized tomography (CT) scan is an important strategy that quantifies the severity of COVID-19 pneumonia. To what extent inactivated COVID-19 vaccines could impact the COVID-19 pneumonia on chest CT is not clear.

METHODS

This study recruited 357 SARS-COV-2 B.1.617.2 (Delta) variant-infected patients admitted to the Second Hospital of Nanjing from July to August 2021. An artificial intelligence-assisted CT imaging system was used to quantify the severity of COVID-19 pneumonia. We compared the volume of infection (VOI), percentage of infection (POI) and chest CT scores among patients with different vaccination statuses.

RESULTS

Of the 357 Delta variant-infected patients included for analysis, 105 were unvaccinated, 72 were partially vaccinated and 180 were fully vaccinated. Fully vaccination had the least lung injuries when quantified by VOI (median VOI of 222.4 cm, 126.6 cm and 39.9 cm in unvaccinated, partially vaccinated and fully vaccinated, respectively; p < 0.001), POI (median POI of 7.60%, 3.55% and 1.20% in unvaccinated, partially vaccinated and fully vaccinated, respectively; p < 0.001) and chest CT scores (median CT score of 8.00, 6.00 and 4.00 in unvaccinated, partially vaccinated and fully vaccinated, respectively; p < 0.001). After adjustment for age, sex, comorbidity, time from illness onset to hospitalization and viral load, fully vaccination but not partial vaccination was significantly associated with less lung injuries quantified by VOI {adjust coefficient[95%CI] for "full vaccination": - 106.10(- 167.30,44.89); p < 0.001}, POI {adjust coefficient[95%CI] for "full vaccination": - 3.88(- 5.96, - 1.79); p = 0.001} and chest CT scores {adjust coefficient[95%CI] for "full vaccination": - 1.81(- 2.72, - 0.91); p < 0.001}. The extent of reduction of pulmonary injuries was more profound in fully vaccinated patients with older age, having underlying diseases, and being female sex, as demonstrated by relatively larger absolute values of adjusted coefficients. Finally, even within the non-severe COVID-19 population, fully vaccinated patients were found to have less lung injuries.

CONCLUSION

Fully vaccination but not partially vaccination could significantly protect lung injury manifested on chest CT. Our study provides additional evidence to encourage a full course of vaccination.

摘要

背景

胸部计算机断层扫描(CT)是量化 COVID-19 肺炎严重程度的重要策略。灭活的 COVID-19 疫苗在多大程度上会影响胸部 CT 上的 COVID-19 肺炎尚不清楚。

方法

本研究招募了 2021 年 7 月至 8 月期间因 SARS-COV-2 B.1.617.2(Delta)变异株感染而入住南京第二医院的 357 名患者。使用人工智能辅助 CT 成像系统来量化 COVID-19 肺炎的严重程度。我们比较了不同疫苗接种状态患者的感染体积(VOI)、感染百分比(POI)和胸部 CT 评分。

结果

在纳入分析的 357 名 Delta 变异株感染患者中,105 名未接种疫苗,72 名部分接种疫苗,180 名完全接种疫苗。完全接种疫苗时肺部损伤最小,VOI(未接种、部分接种和完全接种组的中位数 VOI 分别为 222.4cm、126.6cm 和 39.9cm;p<0.001)、POI(未接种、部分接种和完全接种组的中位数 POI 分别为 7.60%、3.55%和 1.20%;p<0.001)和胸部 CT 评分(未接种、部分接种和完全接种组的中位数 CT 评分分别为 8.00、6.00 和 4.00;p<0.001)。在校正年龄、性别、合并症、发病到住院时间和病毒载量后,完全接种疫苗但不是部分接种疫苗与 VOI 量化的肺部损伤减少显著相关{“完全接种疫苗”的调整系数[95%CI]:-106.10(-167.30,44.89);p<0.001}、POI{“完全接种疫苗”的调整系数[95%CI]:-3.88(-5.96,-1.79);p=0.001}和胸部 CT 评分{“完全接种疫苗”的调整系数[95%CI]:-1.81(-2.72,-0.91);p<0.001}。在年龄较大、有基础疾病和女性的完全接种疫苗患者中,肺部损伤减少的程度更为明显,调整后的系数绝对值较大。最后,即使在非重症 COVID-19 人群中,完全接种疫苗的患者肺部损伤也较少。

结论

完全接种疫苗而不是部分接种疫苗可以显著保护胸部 CT 上的肺部损伤。我们的研究提供了额外的证据,鼓励进行全程接种。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b01/10031985/d600f2bae416/12941_2023_569_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b01/10031985/d600f2bae416/12941_2023_569_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b01/10031985/d600f2bae416/12941_2023_569_Fig1_HTML.jpg

相似文献

1
Impact of inactivated COVID-19 vaccines on lung injury in B.1.617.2 (Delta) variant-infected patients.灭活新冠病毒疫苗对 B.1.617.2(德尔塔)变异株感染患者肺损伤的影响。
Ann Clin Microbiol Antimicrob. 2023 Mar 21;22(1):22. doi: 10.1186/s12941-023-00569-z.
2
SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status - Los Angeles County, California, May 1-July 25, 2021.2021 年 5 月 1 日至 7 月 25 日,加利福尼亚州洛杉矶县≥16 岁人群中,根据疫苗接种状况划分的 SARS-CoV-2 感染和住院情况。
MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1170-1176. doi: 10.15585/mmwr.mm7034e5.
3
Pneumonia Frequency and Severity in Patients With Symptomatic COVID-19: Impact of mRNA and Adenovirus Vector Vaccines.症状性 COVID-19 患者的肺炎频率和严重程度:mRNA 和腺病毒载体疫苗的影响。
AJR Am J Roentgenol. 2022 Nov;219(5):752-761. doi: 10.2214/AJR.22.27843. Epub 2022 Jun 1.
4
Effectiveness of inactivated COVID-19 vaccines against severe illness in B.1.617.2 (Delta) variant-infected patients in Jiangsu, China.中国江苏 B.1.617.2(Delta)变异株感染者中新冠灭活疫苗对重症的保护效果。
Int J Infect Dis. 2022 Mar;116:204-209. doi: 10.1016/j.ijid.2022.01.030. Epub 2022 Jan 19.
5
Effectiveness of adenovirus type 5 vectored and inactivated COVID-19 vaccines against symptomatic COVID-19, COVID-19 pneumonia, and severe COVID-19 caused by the B.1.617.2 (Delta) variant: Evidence from an outbreak in Yunnan, China, 2021.腺病毒 5 型载体疫苗和灭活 COVID-19 疫苗对由 B.1.617.2(德尔塔)变异株引起的有症状 COVID-19、COVID-19 肺炎和重症 COVID-19 的有效性:来自中国云南 2021 年暴发疫情的证据。
Vaccine. 2022 May 3;40(20):2869-2874. doi: 10.1016/j.vaccine.2022.03.067. Epub 2022 Apr 1.
6
Transmission and Infectious SARS-CoV-2 Shedding Kinetics in Vaccinated and Unvaccinated Individuals.接种疫苗和未接种疫苗个体中的 SARS-CoV-2 传播和传染性脱落动力学。
JAMA Netw Open. 2022 May 2;5(5):e2213606. doi: 10.1001/jamanetworkopen.2022.13606.
7
Mental health and chest CT scores mediate the relationship between COVID-19 vaccination status and seroconversion time: A cross-sectional observational study in B.1.617.2 (Delta) infection patients.心理健康和胸部 CT 评分在 COVID-19 疫苗接种状态和血清转换时间之间的关系中起中介作用:一项在 B.1.617.2(Delta)感染患者中的横断面观察性研究。
Front Public Health. 2022 Oct 19;10:974848. doi: 10.3389/fpubh.2022.974848. eCollection 2022.
8
[Clinical features of children with coronavirus disease 2019 Delta variant infection after vaccination with inactivated SARS-CoV-2 vaccine].[2019年冠状病毒病Delta变异株感染儿童接种新型冠状病毒灭活疫苗后的临床特征]
Zhongguo Dang Dai Er Ke Za Zhi. 2022 Jul 15;24(7):742-747. doi: 10.7499/j.issn.1008-8830.2203174.
9
Imaging Severity COVID-19 Assessment in Vaccinated and Unvaccinated Patients: Comparison of the Different Variants in a High Volume Italian Reference Center.接种疫苗和未接种疫苗患者的COVID-19影像严重程度评估:意大利一家大型参考中心不同变体的比较
J Pers Med. 2022 Jun 10;12(6):955. doi: 10.3390/jpm12060955.
10
Analysis of CT signs, radiomic features and clinical characteristics for delta variant COVID-19 patients with different vaccination status.分析不同疫苗接种状态的德尔塔变异株 COVID-19 患者的 CT 征象、影像组学特征和临床特征。
BMC Med Imaging. 2022 Nov 29;22(1):209. doi: 10.1186/s12880-022-00937-9.

本文引用的文献

1
Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern: a systematic review and meta-analysis.COVID-19 疫苗对关注的 SARS-CoV-2 变异株的有效性:系统评价和荟萃分析。
BMC Med. 2022 May 23;20(1):200. doi: 10.1186/s12916-022-02397-y.
2
Effectiveness of inactivated COVID-19 vaccines against severe illness in B.1.617.2 (Delta) variant-infected patients in Jiangsu, China.中国江苏 B.1.617.2(Delta)变异株感染者中新冠灭活疫苗对重症的保护效果。
Int J Infect Dis. 2022 Mar;116:204-209. doi: 10.1016/j.ijid.2022.01.030. Epub 2022 Jan 19.
3
Comparison of chest CT severity scoring systems for COVID-19.
COVID-19 患者胸部 CT 严重程度评分系统比较。
Eur Radiol. 2022 May;32(5):3501-3512. doi: 10.1007/s00330-021-08432-5. Epub 2022 Jan 15.
4
Comparison of semiquantitative chest CT scoring systems to estimate severity in coronavirus disease 2019 (COVID-19) pneumonia.比较半定量胸部 CT 评分系统以评估 2019 冠状病毒病(COVID-19)肺炎的严重程度。
Eur Radiol. 2022 May;32(5):3513-3524. doi: 10.1007/s00330-021-08435-2. Epub 2022 Jan 12.
5
Severity of Illness in Persons Infected With the SARS-CoV-2 Delta Variant vs Beta Variant in Qatar.在卡塔尔感染 SARS-CoV-2 的德尔塔变异株和贝塔变异株患者的疾病严重程度。
JAMA Intern Med. 2022 Feb 1;182(2):197-205. doi: 10.1001/jamainternmed.2021.7949.
6
Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis.新冠疫苗的真实世界有效性:文献综述和荟萃分析。
Int J Infect Dis. 2022 Jan;114:252-260. doi: 10.1016/j.ijid.2021.11.009. Epub 2021 Nov 17.
7
Development and validation of a clinical prediction model to estimate the risk of critical patients with COVID-19.开发和验证一种临床预测模型,以估计 COVID-19 危重症患者的风险。
J Med Virol. 2022 Mar;94(3):1104-1114. doi: 10.1002/jmv.27428. Epub 2021 Nov 6.
8
Sex Disparities in Efficacy in COVID-19 Vaccines: A Systematic Review and Meta-Analysis.新冠疫苗效力的性别差异:一项系统评价与荟萃分析
Vaccines (Basel). 2021 Jul 27;9(8):825. doi: 10.3390/vaccines9080825.
9
Effectiveness of inactivated SARS-CoV-2 vaccines against the Delta variant infection in Guangzhou: a test-negative case-control real-world study.在广州,灭活的 SARS-CoV-2 疫苗对 Delta 变异株感染的有效性:一项病例对照的真实世界研究。
Emerg Microbes Infect. 2021 Dec;10(1):1751-1759. doi: 10.1080/22221751.2021.1969291.
10
Viral load and disease severity in COVID-19.新冠病毒载量与疾病严重程度。
Intern Emerg Med. 2022 Mar;17(2):359-367. doi: 10.1007/s11739-021-02786-w. Epub 2021 Jun 16.